Ernexa Therapeutics Inc.
NASDAQERNA short interest falls 21.7% in a week to 1.94% of float, though cost to borrow remains elevated at 165.8%.
Short interest % of float, cost to borrow, utilization, and put/call ratio for ERNA are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 6 May 2026
No long-form analysis yet for ERNA. Pulse alerts and the live data picture are available on ORTEX.
Open ERNA on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ERNA — free to start on ORTEX.
Sign up for free →Open ERNA on ORTEX